Open AccessInfant Respiratory Syncytial Virus Bronchiolitis and Subsequent Risk of Pneumonia, Otitis Media, and Antibiotic Utilization
Author(s) -
Alexander Abreo,
Pingsheng Wu,
Brittney M. Donovan,
Tan D,
Tebeb Gebretsadik,
Xiang Huang,
Cosby A. Stone,
Kedir N. Turi,
Tina V. Hartert
Publication year - 2019
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz1033
Subject(s) - bronchiolitis , medicine , otitis , pneumonia , pneumovirus , antibiotics , respiratory system , virus , vaccination , respiratory disease , immunology , paramyxoviridae , pediatrics , viral disease , microbiology and biotechnology , surgery , lung , biology
Infant respiratory syncytial virus (RSV) bronchiolitis in the first 6 months of life was associated with increased odds of pneumonia, otitis media, and antibiotic prescription fills in the second 6 months of life. These data suggest a potential value of future RSV vaccination programs on subsequent respiratory health.